Comparing Cystatin C changes as a measure of renal function before and after radiotherapy in patients with stomach cancer

Acta Medica Iranica

Volumn 50, Issue 1, 2012, Pages 43-46

  Rasouli, Hooshang Amir ^a   Moghadam, Maryam Mirzaie ^a   Tabatabaiefar, Morteza ^a   Taslimi, Farnaz ^a   Sheybani, Khosro Mojir ^a   Alidoosti, Asadollah ^a   Ameri, Ahmad ^a   Fadavi, Pedram ^b   Aref, Shahrzad ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cystatin C; Radiotherapy; Stomach neoplasms

Indexed keywords

CAPECITABINE; CREATININE; CYSTATIN C; NITROGEN; UREA;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IRAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; NEPHELOMETRY; PROSPECTIVE STUDY; RADIATION DOSE; STOMACH CANCER; UREA NITROGEN BLOOD LEVEL;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CHEMORADIOTHERAPY; CREATININE; CYSTATIN C; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; GLOMERULAR FILTRATION RATE; HUMANS; IRAN; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIATION DOSAGE; RADIATION INJURIES; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856046097     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schwartz CL. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 1999;4(1):45-54.
2. Gunderson LL, Hoskins RB, Cohen AC, Kaufman S, Wood WC, Carey RW. Combined modality treatment of gastric cancer. Int J Radiat Oncol Biol Phys 1983;9(7):965-75.
3. Henning GT, Schild SE, Stafford SL, Donohue JH, Burch PA, Haddock MG, Trastek VF, Gunderson LL. Results of irradiation or chemoirradiation following resection of gastric adenocarcinoma. Int J Radiat Oncol Biol Phys 2000;46(3):589-98.
4. Willett CG, Tepper JE, Orlow EL, Shipley WU. Renal complications secondary to radiation treatment of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 1986;12(9):1601-4.
5. Rubin P, Casarett GW, editors. Clinical Radiation Pathology. Vols. I and I. Philadelphia, PA: WB Saunders; 1968.
6. Verheij M, Stewart FA, Oussoren Y, Weening JJ, Dewit L. Amelioration of radiation nephropathy by acetylsalicylic acid. Int J Radiat Biol 1995;67(5):587-96.
7. Kasiske BL, Keane WF. Laboratory assessment of renal disease: clearance, urinalysis and renal biopsy. ln: Brenner BM, Rector FC, editors. The Kidney. 5th ed. Philadelphia, PA: WB Saunders; 1996. p. 727-8.
8. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992;38(10):1933-53.
9. Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate? Clin Chem 2002;48(5):699-707.
10. Devarajan P. Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol 2007;27(6):637-51.
11. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harisson's Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2001.
12. Adreoli TE, Carpenter CC, Griggs RC, Loscalzo J, editors. Cecil Essential of medicine. 5th ed. Philadelphia, PA: WB Saunders; 2001. p. 223-37.
13. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003;18(10):2024-31.
14. Macisaac RJ, Tsalamandris C, Thomas MC, Premaratne E, Panagiotopoulos S, Smith TJ, Poon A, Jenkins MA, Ratnaike SI, Power DA, Jerums G. The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetes. Diabet Med 2007;24(4):443-8.
15. Cruz DN, Perazella MA, Mahnensmith RL. Bone marrow transplant nephropathy: a case report and review of the literature. J Am Soc Nephrol 1997;8(1):166-73.
16. Stabuc B, Vrhovec L, Stabuc-Silih M, Cizej TE. Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy. Clin Chem 2000;46(2):193-7.
17. Tabatabaeifar M, Moeani B, Amirrasooli H, Rahbar Kh, Valaei N, Taslimi F. The efficacy of serum cystatin C and creatinine due to diagnosis of impaired renal function in cancerous paitients treated with chemotherapeutic agents such as Cisplatin. Pejouhandeh J 2008;5(13):375-81. [Persian].